Nova Patents
AT245437T

Vascular endothelial growth factor-b

Abstract

And the centre vascular endothelial battery mitosis and a VEGF-B comprising a growth factor PDGF family, codes are polypeptides the DNA sequences, comprising parallel pharmaceutical compositions, and at every reaction antibodies. The VEGF-B polypeptides of the be used to stimulate of the angiogenesis and a diagnosis and.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

33 members in 16 offices

This recordMember, by publication datePriority claim6 more offices are in the list below

Priority claims4

Priority claims
DocumentOfficeKindDate
39765195United States of AmericaA
46942795United States of AmericaA
56906395United States of AmericaA
9602957United States of AmericaW

Members33

Family members, oldest first
DocumentOfficeKind
ZA961686BSouth AfricaB
CA2211687A1CanadaA1
WO9626736A1World Intellectual Property Organization (WIPO)A1
AU5302196AAustraliaA
US5607918AUnited States of AmericaA
NO973933D0NorwayD0
NO973933LNorwayL
EP0814827A1European Patent Office (EPO)A1
CN1176603AChinaA
JPH10510718AJapanA
US5840693AUnited States of AmericaA
NZ305091ANew ZealandA
US5928939AUnited States of AmericaA
HK1008485A1Hong Kong, ChinaA1
EP0814827A4European Patent Office (EPO)A4
JP2000228982AJapanA
AU741856B2AustraliaB2
US6331301B1United States of AmericaB1
JP3275024B2JapanB2
JP3297687B2JapanB2
EP0814827B1European Patent Office (EPO)B1
AT245437TThis recordAustriaT
ATE245437T1AustriaT1
DE69629181D1GermanyD1
US2003170253A1United States of AmericaA1
DK0814827T3DenmarkT3
PT814827EPortugalE
ES2202432T3SpainT3
CN1146440CChinaC
DE69629181T2GermanyT2
US2005064493A1United States of AmericaA1
US7341996B2United States of AmericaB2
CA2211687CCanadaC